Skip to main content

Fresenius Q2/25: Guidance raised - Resilient business continues to deliver consistent performance

Conference Call Q2 2025

August 06, 2025 - 01:30 pm
Bad Homburg, Germany

Conference Call Q2 2025

Latest

Financial Highlights Q2/2025

Group Revenue 1

5571 m

+5% 2

Q2/24: €5,414 m

Group EBIT 1

654 m

+0% 3

Q2/24: €660 m

Net income 1, 4

412 m

+8% 3

Q2/24: €388 m

EPS 1, 4

0.73

+8% 3

Q2/24: €0.69

KABI Revenue 1

2111 m

+6% 2

Q2/24: €2,101 m

HELIOS Revenue

3370 m

+5% 1

Q2/24: €3,230 m

1 Before special items

2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation

3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation

4 Excluding Fresenius Medical Care

2024 – What a successful year!

Listen to CEO Michael Sen on how our #FutureFresenius transformation is clearly paying off: today, we are a simpler, more focused, and stronger healthcare company.

Tune in!

 

News